Most Clicked DiabetesPro SmartBrief Stories


1. GSK gains FDA nod for type 2 diabetes drug

DiabetesPro SmartBrief | Apr 16, 2014

The FDA has granted GlaxoSmithKline approval for its Tanzeum drug to boost glucose control in type 2 diabetes patients. HealthDay News (04/15)


2. GLP-1 plus insulin may spur extended hypoglycemia in diabetes

DiabetesPro SmartBrief | Apr 10, 2014

A combination of glucagon-like peptide 1 and insulin was associated with longer-lasting hypoglycemia in patients with type 2 diabetes, according to a small study in Diabetes Care. Researchers said the combination treatment delays gastric emptying in patients, which can lead to an increased risk of extended hypoglycemia. Diabetes.co.uk (U.K.) (04/09)


3. Multifactorial treatment cuts mortality risk in type 2 diabetes

DiabetesPro SmartBrief | Apr 11, 2014

A study in Diabetes Care showed patients with type 2 diabetes and nephropathy who underwent multifactorial treatment had a lower mortality risk compared with a cohort of patients treated between 1983 and 2002, before the implementation of multifactorial intervention. Multifactorial therapy was also associated with a lower rate of decline in glomerular filtration rate. MedWire News (U.K.) (04/10)


4. U.S. diabetes, prediabetes rates continue to climb, data show

DiabetesPro SmartBrief | Apr 15, 2014

A study in the Annals of Internal Medicine says the rate of both undiagnosed and diagnosed diabetes in the U.S. grew from 5.5% between 1988 and 1994 to 9.3% between 2005 and 2010. Researchers also found that prediabetes rates went from less than 6% to more than 12% during the study period, while obesity rates among diabetes patients grew from 44% to 61%. U.S. News & World Report (04/14)


5. FDA clears A1C test from Abbott Laboratories

DiabetesPro SmartBrief | Apr 16, 2014

Abbott Laboratories received FDA clearance for its ARCHITECT clinical chemistry A1C test designed to boost diabetes diagnosis and monitoring and identify patients at risk of the condition. RTT News (04/14)


6. Diabetes in pregnancy may raise risk of birth defects

DiabetesPro SmartBrief | Apr 14, 2014

The likelihood of having a baby with physical birth defects was 86% and 26% greater among women with pre-gestational diabetes and gestational diabetes, respectively, according to a study in the journal Diabetes Care. Researchers noted that pre-gestational diabetes also was associated with a higher risk of perinatal mortality. DailyRx.com (04/11)


7. Protein intake influences diabetes risk, study says

DiabetesPro SmartBrief | Apr 16, 2014

People who had the highest intake of animal protein had a 22% higher risk of developing type 2 diabetes than those who ate the least amount, a study in Diabetes Care indicated. Researchers also noted a 6% increased risk of diabetes for every additional 10 grams of protein consumed daily. Reuters (04/15)


8. Study: Once-weekly exenatide improves A1C in diabetes

DiabetesPro SmartBrief | Apr 15, 2014

Once-weekly exenatide fared better than insulin glargine in lowering A1C in insulin-naive type 2 diabetes patients during a three-year follow-up, a study in The Lancet Diabetes & Endocrinology revealed. Adverse intestinal side effects such as nausea and diarrhea were more frequent in the exenatide arm but declined at 26 weeks of treatment. Healio (free registration) (04/11)


9. Diabetes drugs among costliest medications

DiabetesPro SmartBrief | Apr 11, 2014

Diabetes drugs are among the 10 costliest traditional medications, according to data from Express Scripts. Researchers projected annual growth of 10% to 13% in consumer spending on diabetes drugs through 2016. Overall, the use of medications grew 0.5% from 2012 to 2013, but consumer spending increased nearly 5% during the period. Medical Marketing & Media (04/09)


10. Heavier teens show greater insulin resistance than adult peers

DiabetesPro SmartBrief | Apr 11, 2014

German researchers found heavier teens appeared to be more insulin-resistant and showed higher total body fat mass than their sex- and BMI-matched adult counterparts, despite having lower visceral fat mass. Liver fat content also appeared to be an independent marker of insulin resistance as early as adolescence, researchers reported in the journal Obesity. Healio (free registration) (04/10)




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more